The launching ceremony of the “SSCLF Charity Funding Project for Children with Retinoblastoma” was held on June 9, 2021 at Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine. Mr. Fan Xianqun, Dean of Shanghai Jiao Tong University School of Medicine, Ms. Zhang Ming, Secretary General of Shanghai Soong Ching Ling Foundation, Mr. Zhang Wei, President of CASI Pharmaceuticals, and ophthalmologists from Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine and Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine were present.
SSCLF signed a donation agreement with the donor, CASI Pharmaceuticals, and signed a project memorandum with Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine and Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine.
Retinoblastoma is the most common intraocular malignant tumor in children, which can lead to blindness and even death, causing great suffering and financial burden to families. With the support of the caring company, the “SSCLF Charity Funding Project for Children with Retinoblastoma”, together with the ophthalmology teams from Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine and Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, will cover some of the surgery costs for children with retinoblastoma in remote areas to alleviate the financial burden of the affected families, thereby helping to save the children’s eyes and lives.